Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
ÌÇÐÄ´«Ã½
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer cell Whisenant, J. G., Trama, A., Torri, V., De Toma, A., Viscardi, G., Cortellini, A., Micheilin, O., Barlesi, F., Dingemans, A. C., Van Meerbeeck, J., Pancaldi, V., Soo, R. A., Leighl, N. B., Peters, S., Wakelee, H., Garassino, M. C., Horn, L. 2020Abstract
Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.
View details for
View details for